| Parameter | All patients | Community‐managed | Hospitalised |
|---|---|---|---|
| Number of participants | 65 | 56 | 9 |
| Time from COVID‐19 diagnosis to first lung function (days), median (IQR) | 113 (105–131) | 115 (107–139) | 74 (63–98) |
| Pre‐bronchodilator FEV1 (% predicted 7 ), median (IQR) | 99 (84–104) | 99 (84–105) | 97 (78–103) |
| FEV1 < lower limit of normal | 5 | 4 | 1 |
| Pre‐bronchodilator FVC (% predicted 7 ), median (IQR) | 106 (97–117) | 105 (97–117) | 106 (89–118) |
| FVC < lower limit of normal | 3 | 2 | 1 |
| FEV1/FVC, mean (SD) | 74 (9.0) | 74 (8.7) | 71 (11) |
| Total lung capacity (% predicted 8 ), median (IQR) | 101 (91–107) | 102 (92–107) | 91 (78–99) |
| Total lung capacity < lower limit of normal | 8 | 6 | 2 |
| Dlco cor (% predicted 9 ), median (IQR) | 92 (84–103) | 93 (85–103) | 89 (62–99) |
| DLCOcor < lower limit of normal | 11 | 8 | 3 |
| Capillary Po 2 (mmHg), mean (SD) | 86 (9.6) | 87 (9.5) | 82 (9.8) |
| Alveolar–arterial gradient (mmHg), mean (SD) | 24 (9.6) | 23 (9.3) | 29 (10) |
COVID‐19 = coronavirus disease 2019; DLCOcor = diffusing capacity of the lung for carbon monoxide, adjusted for haemoglobin concentration; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; IQR = interquartile range; Po 2 = partial pressure of oxygen; SD = standard deviation.